TNF and inflammatory bowel disease: TNF-α inhibitors are well-established treatments for a range of severe immunoinflammatory diseases and have demonstrated substantial clinical benefit in conditions such as rheumatoid arthritis and inflammatory bowel disease (IBD) [4–6].